Search details
1.
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
JAMA
; 331(3): 201-211, 2024 01 16.
Article
in English
| MEDLINE | ID: mdl-38227033
2.
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
Semin Cancer Biol
; 86(Pt 3): 960-970, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35189321
3.
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT).
BMC Med
; 21(1): 72, 2023 02 24.
Article
in English
| MEDLINE | ID: mdl-36829154
4.
A randomized, double-blind, placebo-controlled study of B-cell lymphoma 2 homology 3 mimetic gossypol combined with docetaxel and cisplatin for advanced non-small cell lung cancer with high expression of apurinic/apyrimidinic endonuclease 1.
Invest New Drugs
; 38(6): 1862-1871, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32529467
5.
Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor ß-dependent manner in human osteosarcoma.
Cancer Sci
; 106(10): 1394-401, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26250694
6.
A population-based study elicits a reverse correlation between age and overall survival in elderly patients with rectal carcinoma receiving adjuvant chemotherapy.
Clin Exp Pharmacol Physiol
; 42(7): 752-65, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25966617
7.
FokI polymorphism in vitamin D receptor gene and risk of breast cancer among Caucasian women.
Tumour Biol
; 35(4): 3503-8, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24318991
8.
Genetic polymorphism of APE1 rs1130409 can contribute to the risk of lung cancer.
Tumour Biol
; 35(7): 6665-71, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24705777
9.
A method for generating large datasets of organ geometries for radiotherapy treatment planning studies.
Radiol Oncol
; 48(4): 408-15, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25435856
10.
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE).
J Thorac Oncol
; 19(6): 912-927, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38280448
11.
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening.
Recent Pat Anticancer Drug Discov
; 2023 Oct 18.
Article
in English
| MEDLINE | ID: mdl-37877147
12.
Frequently mutated genes in predicting the relapse of stage I lung adenocarcinoma.
Clin Transl Oncol
; 25(6): 1767-1778, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-36739576
13.
Human apurinic/apyrimidinic endonuclease 1 translocalizes to mitochondria after photodynamic therapy and protects cells from apoptosis.
Cancer Sci
; 103(5): 882-8, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22329793
14.
A Novel Intergenic Gene Between SLC8A1 and PKDCC-ALK Fusion Responds to ALK TKI WX-0593 in Lung Adenocarcinoma: A Case Report.
Front Oncol
; 12: 898954, 2022.
Article
in English
| MEDLINE | ID: mdl-35847849
15.
Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer.
Cancer Med
; 11(1): 268-280, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34799997
16.
The Predictive Value of Three Variables in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis.
J Oncol
; 2022: 7733251, 2022.
Article
in English
| MEDLINE | ID: mdl-36124031
17.
Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial.
Signal Transduct Target Ther
; 7(1): 25, 2022 01 28.
Article
in English
| MEDLINE | ID: mdl-35087031
18.
LncRNA-PANDAR regulates the progression of thyroid carcinoma by targeting miR-637/KLK4.
J Cancer
; 12(19): 5879-5887, 2021.
Article
in English
| MEDLINE | ID: mdl-34476001
19.
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
J Clin Oncol
; 39(27): 3002-3011, 2021 09 20.
Article
in English
| MEDLINE | ID: mdl-34185551
20.
MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
J Gastroenterol Hepatol
; 25(1): 164-71, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19793168